Serum proteins and paraproteins in women with silicone implants and connective tissue disease: A case-control study

Arthritis Research and Therapy

Volumn 9, Issue 5, 2007, Pages

  Csako, Gyorgy ^a   Costello, Rene ^a   Shamim, Ejaz A ^b   O'Hanlon, Terrance P ^b   Tran, Anthony ^a,c   Clauw, Daniel J ^d   Williams, H James ^e   Miller, Frederick W ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c ASSOCIATION OF PUBLIC HEALTH LABORATORIES   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 GLOBULIN; ALPHA 2 GLOBULIN; BETA GLOBULIN; GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARAPROTEIN; PLASMA PROTEIN; PROTEIN; SILICONE GEL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST ENDOPROSTHESIS; CASE CONTROL STUDY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; PARAPROTEINEMIA; PATHOGENESIS; POLYMYOSITIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SILICONE PROSTHESIS; AGED; BLOOD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BLOOD PROTEINS; BREAST IMPLANTS; CASE-CONTROL STUDIES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MIDDLE AGED; PARAPROTEINEMIAS; PARAPROTEINS; PROSPECTIVE STUDIES; RISK FACTORS; SILICONE GELS;

EID: 36448929417     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2295     Document Type: Article

References (48)

1. Gabriel SE Woods JE O'Fallon WM Beard CM Kurland LT Melton LJ III Complications leading to surgery after breast implantation N Engl J Med 1997, 336:677-682. 10.1056/NEJM199703063361001 9041097
2. Kulmala I McLaughlin JK Pakkanen M Lassila K Holmich LR Lipworth L Boice JD Jr Raitanen J Luoto R Local complications after cosmetic breast implant surgery in Finland Ann Plast Surg 2004, 53:413-419. 10.1097/ 01.sap.0000131275.62449.c8 15502454
3. Park AJ Black RJ Watson AC Silicone gel breast implants, breast cancer and connective tissue disorders Br J Surg 1993, 80:1097-1100. 10.1002/ bjs.1800800907 8402103
4. Gerszten PC A formal risk assessment of silicone breast implants Biomaterials 1999, 20:1063-1069. 10.1016/S0142-9612(99)00008-3 10378807
5. Perkins LL Clark BD Klein PJ Cook RR A meta-analysis of breast implants and connective tissue disease Ann Plast Surg 1995, 35:561-570. 10.1097/ 00000637-199512000-00001 8748335
6. Wong O A critical assessment of the relationship between silicone breast implants and connective tissue diseases Regul Toxicol Pharmacol 1996, 23:74-85. 10.1006/rtph.1996.0011 8628923
7. Hochberg MC Perlmutter DL The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): A meta-analysis Curr Top Microbiol Immunol 1996, 210:411-417. 8565585
8. Janowsky EC Kupper LL Hulka BS Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases N Engl J Med 2000, 342:781-790. 10.1056/NEJM200003163421105 10717013
9. Potter M Morrison S Wiener F Zhang XK Miller FW Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice J Natl Cancer Inst 1994, 86:1058-1065. 10.1093/jnci/86.14.1058 8021954
10. Tricot GJ Naucke S Vaught L Vesole D Jagannath S Barlogie B Is the risk of multiple myeloma increased in patients with silicone implants? Curr Top Microbiol Immunol 1996, 210:357-359. 8565577
11. Garland LL Ballester OF Vasey FB Benson K Moscinski LC Farmelo MJ Rodriguez MJ Rapaport DP Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk Curr Top Microbiol Immunol 1996, 210:361-366. 8565578
12. Silverman S Vescio R Silver D Renner S Weiner S Berenson J Silicone gel implants and monoclonal gammopathies: Three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance Curr Top Microbiol Immunol 1996, 210:367-734. 8565579
13. Karlson EW Tanasijevic M Hankinson SE Liang MH Colditz GA Speizer FE Schur PH Monoclonal gammopathy of undetermined significance and exposure to breast implants Arch Intern Med 2001, 161:864-867. 10.1001/ archinte.161.6.864 11268230
14. Karlson EW Hankinson SE Liang MH Sanchez-Guerrero J Colditz GA Rosenau BJ Speizer FE Schur PH Association of silicone breast implants with immunologic abnormalities: A prospective study Am J Med 1999, 106:11-19. 10.1016/S0002-9343(98)00358-1 10320112
15. Broggini M Cavallo A Baratelli E Volonte S Crespi E Cappelli A Chelazzi G Monoclonal gammopathy of uncertain significance in rheumatic disease [in Italian] Recenti Prog Med 1990, 81:306-309. 2377807
16. Bohan A Peter JB Bowman RL Pearson CM Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis Medicine (Baltimore) 1977, 56:255-286. 327194
17. Masi A Classification of systemic sclerosis (scleroderma): Relationship of cutaneous subgroups in early disease to outcome and serologic reactivity J Rheumatol 1988, 15:894-898. 3262160
18. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. [Letter] Arthritis Rheum 1997, 40:1725. 10.1002/art.1780400928 9324032
19. Wolfe F Smythe HA Yunus MB Bennett RM Bombardier C Goldenberg DL Tugwell P Campbell SM Abeles M Clark P American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee Arthritis Rheum 1990, 33:160-172. 10.1002/ art.1780330203 2306288
20. Williams HJ Alarcon GS Joks R Steen VD Bulpitt K Clegg DO Ziminski CM Luggen ME St Clair EW Willkens RF Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and undifferentiated CTD J Rheumatol 1999, 26:816-825. 10229402
21. Kyle RA Rajkumar SV Monoclonal gammopathy of undetermined significance Clin Lymphoma Myeloma 2005, 6:102-114. 16231848
22. MacGregor AJ Kalsi J Ravirajan CT Leaker B Watts R Winska-Wiloch H Knight B Norden A Isenberg DA Cambridge G Analysis of antibody reactivity in the sera of 42 patients with paraproteinemia Autoimmunity 1992, 13:101-105. 1467431
23. Jonsson V Svendsen B Vorstrup S Krarup C Schmalbruch H Thomsen K Heegaard NH Wiik A Hansen MM Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia Leukemia 1996, 10:327-332. 8637242
24. Brigden ML The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgrad Med 1999, 106:135-142. 10456045
25. Bataille R Chappard D Basle MF Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: A prospective study of 87 bone biopsies Blood 1996, 87:4762-4769. 8639847
26. Zandecki M Lai JL Genevieve F Bernardi F Volle-Remy H Blanchet O Francois M Cosson A Bauters F Facon T Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition Blood 1997, 90:3682-3690. 9345053
27. Konigsberg R Ackermann J Kaufmann H Zojer N Urbauer E Kromer E Jager U Gisslinger H Schreiber S Heinz R Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance Leukemia 2000, 14:1975-1979. 10.1038/sj.leu.2401909 11069034
28. Almeida J Orfao A Mateo G Ocqueteau M Garcia-Sanz R Moro MJ Hernandez J Ortega F Borrego D Barez A Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance Pathol Biol (Paris) 1999, 47:119-127. 10192879
29. McLaughlin JK Fraumeni JF Jr Olsen J Mellemkjaer L Re: Breast implants, cancer, and systemic sclerosis [letter] J Natl Cancer Inst 1994, 86:1424. 10.1093/jnci/86.18.1424 8072038
30. McLaughlin JK Fraumeni JF Jr Nyren O Adami HO Silicone breast implants and risk of cancer? [Letter] JAMA 1995, 273:116. 10.1001/jama.273.2.116 7799490
31. Kyle RA Monoclonal gammopathy of undetermined significance Curr Top Microbiol Immunol 1996, 210:375-383. 8565580
32. Colls BM Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study Aust N Z J Med 1999, 29:500-504. 10868527
33. Axelsson U Bachman R Hallen J Frequency of pathological proteins (M-components) in 6,995 sera from an adult population Acta Med Scand 1966, 179:235-247. 4160039
34. Saleun JP Vicariot M Deroff P Monoclonal gammopathies in the adult population of Finistère, France J Clin Pathol 1982, 35:63-68. 497449 6801095 10.1136/jcp.35.1.63
35. Kyle RA Therneau TM Rajkumar SV Larson DR Plevak MF Offord JR Dispenzieri A Katzmann JA Melton LJ 3rd Prevalence of monoclonal gammopathy of undetermined significance N Engl J Med 2006, 354:1362-1369. 10.1056/NEJMoa054494 16571879
36. Giraldo MP Rubio-Felix D Perella M Gracia JA Bergua JM Giralt M Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases [in Spanish] Sangre (Barc) 1991, 36:377-382. 1816635
37. Nilsson T Norberg B Rudolphi O Jacobsson L Double gammopathies: incidence and clinical course of 20 patients Scand J Haematol 1986, 36:103-106. 3081993
38. Isobe T Osserman EF Pathologic conditions associated with plasma cell dyscrasias: A study of 806 cases Ann N Y Acad Sci 1971, 190:507-518. 10.1111/j.1749-6632.1971.tb13560.x 5003017
39. Wolf LE Lappe M Peterson RD Ezrailson EG Human immune response to polydimethylsiloxane (silicone): Screening studies in a breast implant population FASEB J 1993, 7:1265-1268. 8405812
40. Smalley DL Shanklin DR Hall MF Monocyte-dependent stimulation of human T cells by silicon dioxide Pathobiology 1998, 66:302-305. 10.1159/ 000028037 9769477
41. Zandman-Goddard G Blank M Ehrenfeld M Gilburd B Peter J Shoenfeld Y A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants J Rheumatol 1999, 26:73-77. 9918243
42. O'Hanlon T Koneru B Bayat E Love L Targoff I Malley J Malley K Miller F Environmental Myositis Study Group Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops Arthritis Rheum 2004, 50:3646-3650. 10.1002/art.20587 15529361
43. McDermott MR Brook MA Bartzoka V Adjuvancy effect of different types of silicone gel J Biomed Mater Res 1999, 46:132-134. 10.1002/ (SICI)1097-4636(199907)46:1<132::AID-JBM15>3.0.CO;2-I 10357144
44. Potter M Morrison S Plasmacytoma development in mice injected with silicone gels Curr Top Microbiol Immunol 1996, 210:397-407. 8565584
45. Schoaib BO Patten BM Calkins DS Adjuvant breast disease. An evaluation of 100 symptomatic women with breast implants or silicone fluid injections Keio J Med 1994, 43:79-87. 8089958
46. Naim JO Satoh M Buehner NA Ippolito KM Yoshida H Nusz D Kurtelawicz L Cramer SF Reeves WH Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice Clin Diagn Lab Immunol 2000, 7:366-370. 95880 10799447 10.1128/CDLI.7.3.366-370.2000
47. Lewy RI Ezrailson E Laboratory studies in breast implant patients: ANA positivity, gammaglobulin levels, and other autoantibodies Curr Top Microbiol Immunol 1996, 210:337-3353. 8565576
48. Bridges AJ Conley C Wang G Burns DE Vasey FB A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease Ann Intern Med 1993, 118:929-936. 8489106